BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Cancer New TP53 stabilizers disclosed in Shanghai Qilu Pharmaceutical patent Dec. 3, 2025 Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has divulged cellular tumor antigen p53 (TP53) (Tyr220Cys mutant) stabilizers reported to be useful for the treatment of cancer. BioWorld ScienceCancerPatents